Search

Author/Creator Terrault, N. A.

1. All‐oral direct‐acting antiviral therapy in HCV‐advanced liver disease is effective in real‐world practice: observations through HCV‐TARGET database. Issue 1 (28th October 2016)

Authors:
Reddy, K. R.; Lim, J. K.; Kuo, A.; Di Bisceglie, A. M.; Galati, J. S.; Morelli, G.; Everson, G. T.; Kwo, P. Y.; Brown, R. S.; Sulkowski, M. S.; Akuschevich, L.; Lok, A. S.; Pockros, P. J.; Vainorius, M.; Terrault, N. A.; Nelson, D. R.; Fried, M. W.; Manns, M. P.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 45:Issue 1(2017)
Page Start:
115
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Clinical and metabolic effects associated with weight changes and obeticholic acid in non‐alcoholic steatohepatitis. Issue 5 (14th January 2018)

Authors:
Hameed, B.; Terrault, N. A.; Gill, R. M.; Loomba, R.; Chalasani, N.; Hoofnagle, J. H.; Van Natta, M. L.
Other Names:
Allende Daniela investigator.; Dasarathy Srinivasan investigator.; J. McCullough Arthur investigator.; Penumatsa Revathi investigator.; Dasarathy Jaividhya investigator.; E. Lavine Joel investigator.; F. Abdelmalek Manal investigator.; Bashir Mustafa investigator.; Buie Stephanie investigator.; M...
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 47:Issue 5(2018)
Page Start:
645
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end‐stage liver disease. Issue 7 (25th August 2013)

Authors:
Gordon, S. C.; Hamzeh, F. M.; Pockros, P. J.; Hoop, R. S.; Buikema, A. R.; Korner, E. J.; Terrault, N. A.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 38:Issue 7(2013)
Page Start:
784
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Ledipasvir–sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders. Issue 2 (25th January 2017)

Authors:
Walsh, C. E.; Workowski, K.; Terrault, N. A.; Sax, P. E.; Cohen, A.; Bowlus, C. L.; Kim, A. Y.; Hyland, R. H.; Han, B.; Wang, J.; Stamm, L. M.; Brainard, D. M.; McHutchison, J. G.; von Drygalski, A.; Rhame, F.; Fried, M. W.; Kouides, P.; Balba, G.; Reddy, K. R.
Journal:
Haemophilia
Issue:
Volume 23:Issue 2(2017)
Page Start:
198
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosis. Issue 10 (24th March 2014)

Authors:
Saxena, V.; Manos, M. M.; Yee, H. S.; Catalli, L.; Wayne, E.; Murphy, R. C.; Shvachko, V. A.; Pauly, M. P.; Chua, J.; Monto, A.; Terrault, N. A.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 39:Issue 10(2014)
Page Start:
1213
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir‐based therapy. Issue 12 (21st April 2016)

Authors:
Campos‐Varela, I.; Moreno, A.; Morbey, A.; Guaraldi, G.; Hasson, H.; Bhamidimarri, K. R.; Castells, L.; Grewal, P.; Baños, I.; Bellot, P.; Brainard, D. M.; McHutchison, J. G.; Terrault, N. A.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 43:Issue 12(2016)
Page Start:
1319
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗